T45.1
Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
Clinical Classification Guidelines
Excludes Type 1
- poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs (T45.A)
- poisoning by, adverse effect of and underdosing of tamoxifen (T38.6)
Medical Intelligence & Overview
ICD-10 code T45.1 refers to cases involving poisoning, adverse reactions, or underdosing of antineoplastic and immunosuppressive medications. These drugs are vital in cancer treatment and immune system management but can also cause serious health issues if not used properly. This guide aims to provide a patient-friendly overview of the causes, symptoms, diagnosis, and treatment options related to this condition.
Causes & Symptoms
Clinical Causes: Incorrect medication dosing, either too high or too low Accidental ingestion or exposure to these medications Use of expired or contaminated drugs Drug interactions leading to toxicity Patient misuse or non-compliance with prescribed regimens
Key Symptoms: Nausea and vomiting Fatigue and weakness Fever or chills Skin rashes or itching Unusual bleeding or bruising Mouth sores or ulcers Hair loss Signs of infection or immune suppression Signs of organ toxicity such as jaundice or shortness of breath Confusion or neurological changes in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history review, including medication usage and exposure. Blood tests are typically conducted to assess drug levels, organ function, and signs of toxicity. Additional tests such as liver and kidney function tests, complete blood count (CBC), and specific drug assays help confirm the diagnosis. Healthcare providers also evaluate symptoms and may perform imaging or biopsy procedures if necessary to rule out other conditions.
Treatment Protocols: The management of poisoning or adverse effects from these drugs focuses on supporting the patient's vital functions and reducing drug toxicity. This may include: - Discontinuing or adjusting the medication dosage - Administering supportive care such as IV fluids, anti-nausea medications, or medications to manage symptoms - Using specific antidotes if available - Treating infections promptly due to immune suppression - Hospitalization in severe cases for close monitoring and advanced interventions Follow-up care involves monitoring drug levels and organ functions, as well as providing education on safe medication use to prevent future incidents.
Clinical Advice & FAQs
Billing Guidance
Is T45.1 a billable ICD-10 code?
Yes, T45.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.1?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference